Tenaris SA
6.3.2026 01:16:53 CET | Globenewswire | Press release
Securities Transactions by Persons Discharging Managerial Responsibilities under Regulation (EU) No 596/2014 on market abuse
Securities Transactions by Persons Discharging Managerial Responsibilities under Regulation (EU) No 596/2014 on market abuse
LUXEMBOURG, March 05, 2026 (GLOBE NEWSWIRE) -- In compliance with Regulation (EU) No 596/2014 on market abuse and applicable Luxembourg laws and regulations, Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announces that it has received a notification of a securities transaction from a person discharging managerial responsibilities (as defined in such Regulation). As required by such laws and regulations, such notification has been filed with the Luxembourg Commission de Surveillance du Secteur Financier and the Luxembourg Stock Exchange; and can be accessed through the following link: https://www.bourse.lu/oam-search
In addition, information on transactions reported by persons discharging managerial responsibilities in Tenaris is publicly available on the company’s website at: https://www.tenaris.com/en/sustainability/governance-and-ethics/. (see tab “Share transactions” in section “Share capital and votes”).
Tenaris is a leading global supplier of steel tubes and related services for the world’s energy industry and certain other industrial applications.
Giovanni Sardagna
Tenaris
1-888-300-5432
www.tenaris.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Freshworks Inc5.3.2026 23:30:00 CET | Press release
Freshworks Unifies Global Sales Organization to Accelerate Growth
Galapagos NV5.3.2026 22:01:00 CET | Press release
Galapagos Appoints Tania Philipp as Chief Human Resources Officer
CoinShares International Limited5.3.2026 21:20:55 CET | Press release
CoinShares CEO to Participate in Canaccord Genuity Virtual Digital Assets Symposium
Wood Mackenzie5.3.2026 21:11:29 CET | Press release
How the Middle East conflict is reshaping gas and LNG markets
Zealand Pharma5.3.2026 19:45:00 CET | Press release
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom